{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:08:21Z","timestamp":1789978101124,"version":"4.0.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005879","name":"National Centre for Biological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.neuroscience.2019.03.056","type":"journal-article","created":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T09:29:14Z","timestamp":1554629354000},"page":"319-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Dopamine requires unique residues to signal via the serotonin 2A receptor"],"prefix":"10.1016","volume":"439","author":[{"given":"Shuchita","family":"Soman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitradas M.","family":"Panicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2019.03.056_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/B978-0-12-391861-1.00002-2","article-title":"Conformational ensemble view of G protein-coupled receptors and the effect of mutations and ligand binding","volume":"520","author":"Abrol","year":"2013","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0010","first-page":"S17","article-title":"The concise guide to PHARMACOLOGY 2017\/18: G protein-coupled receptors","volume":"174","author":"Alexander","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0015","doi-asserted-by":"crossref","first-page":"14672","DOI":"10.1074\/jbc.271.25.14672","article-title":"Mapping the binding site pocket of the serotonin 5-HT2A receptor","volume":"271","author":"Almaula","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0020","author":"Andrade"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0025","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/j.1538-7836.2011.04476.x","article-title":"Effect of 5-HT2A receptor antagonists on human platelet activation in blood exposed to physiologic stimuli and atherosclerotic plaque","volume":"9","author":"Bampalis","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/mol.54.1.94","article-title":"Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus","volume":"54","author":"Berg","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0035","series-title":"Rapid agonist-induced pathway in vitro internalization of the receptor occurs via the endosome","first-page":"306","author":"Berry","year":"1996"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0040","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/mds.25366","article-title":"Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia","volume":"28","author":"Bezard","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1471-4159.2009.06493.x","article-title":"Differences in the C-terminus contribute to variations in trafficking between rat and human 5-HT2Areceptor isoforms: identification of a primate-specific tripeptide ASK motif that confers GRK-2 and \u03b2 arrestin-2 interactions","volume":"112","author":"Bhattacharya","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0050","doi-asserted-by":"crossref","first-page":"15248","DOI":"10.1073\/pnas.0606578103","article-title":"Activation, internalization, and recycling of the serotonin 2A receptor by dopamine","volume":"103","author":"Bhattacharyya","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0055","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/mds.22792","article-title":"Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease","volume":"25","author":"Carta","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0925-4773(99)00141-0","article-title":"Serotonin synchronises convergent extension of ectoderm with morphogenetic gastrulation movements in Drosophila","volume":"87","author":"Colas","year":"1999","journal-title":"Mech Dev"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0065","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1124\/jpet.108.143040","article-title":"Characterization of serotonin receptors in pregnant human myometrium","volume":"328","author":"Cordeaux","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pneurobio.2016.03.004","article-title":"Serotonergic modulation of the activity of mesencephalic dopaminergic systems: therapeutic implications","volume":"151","author":"De Deurwaerd\u00e8re","year":"2017","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0075","article-title":"Role of phosphorylation in the control of clathrin-mediated internalization of GPCR","volume":"2011","author":"Fessart","year":"2011","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coph.2016.10.006","article-title":"Contribution of heteromerization to G protein-coupled receptor function","volume":"32","author":"Gaitonde","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0085","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1523\/JNEUROSCI.23-26-08836.2003","article-title":"Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex","volume":"23","author":"Gonz\u00e1lez-Maeso","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0090","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/sj.bjp.0704992","article-title":"Smooth muscle 5-HT 2A receptors mediating contraction of porcine isolated proximal stomach strips","volume":"137","author":"Janssen","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0095","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1091\/mbc.e05-10-0980","article-title":"Arf6-independent gpi-anchored protein-enriched early endosomal compartments fuse with sorting endosomes via a rab5 \/ phosphatidylinositol-3 -kinase \u2013 dependent machinery","volume":"17","author":"Kalia","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0165-6147(00)89020-3","article-title":"Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity","volume":"16","author":"Kenakin","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0165-6147(00)89032-X","article-title":"Agonist-receptor efficacy. II. Agonist trafficking of receptor signals","volume":"16","author":"Kenakin","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tips.2004.02.012","article-title":"Principles: receptor theory in pharmacology","volume":"25","author":"Kenakin","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1021\/cn200111m","article-title":"A simple method for quantifying functional selectivity and agonist bias","volume":"3","author":"Kenakin","year":"2012","journal-title":"ACS Chem Nerosci"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejphar.2017.10.053","article-title":"Anti-aggregation effect of aroxyalkyl derivatives of 2-methoxyphenylpiperazine is due to their 5-HT2Aand \u03b12-adrenoceptor antagonistic properties. A comparison with ketanserin, sarpogrelate, prazosin, yohimbine and ARC239","volume":"818","author":"Kubacka","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0165-6147(90)90113-M","article-title":"Role of phosphorylation in desensitization of the \u03b2-adrenoceptor","volume":"11","author":"Lefkowitz","year":"1990","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"issue":"80","key":"10.1016\/j.neuroscience.2019.03.056_bb0135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.1123842","article-title":"Platelet-derived serotonin mediates liver regeneration","volume":"312","author":"Lesurtel","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0140","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.bbamcr.2010.08.010","article-title":"Hetero-dimerization of serotonin 5-HT(2A) and dopamine D(2) receptors","volume":"1803","author":"Lukasiewicz","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0145","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neulet.2011.01.046","article-title":"Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists","volume":"493","author":"Moreno","year":"2011","journal-title":"Neurosci Lett"},{"issue":"410","key":"10.1016\/j.neuroscience.2019.03.056_bb0155","doi-asserted-by":"crossref","first-page":"ra5","DOI":"10.1126\/scisignal.aab0467","article-title":"Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia","volume":"9","author":"Moreno","year":"2016","journal-title":"Sci Signal"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0160","article-title":"Effects of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin","author":"Nakamura","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0165","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"Nichols","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0170","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/cr078224o","article-title":"Serotonin receptors","volume":"108","author":"Nichols","year":"2008","journal-title":"Chem Rev"},{"issue":"4","key":"10.1016\/j.neuroscience.2019.03.056_bb0175","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1046\/j.1471-4159.1995.64041440.x","article-title":"The third intracellular loop of the 5-hydroxytryptamine 2A receptor determines effector coupling specificity","volume":"64","author":"Oksenberg","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/syn.10273","article-title":"Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors","volume":"50","author":"Oz","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0185","series-title":"SourceSerotonin Recept","first-page":"2","article-title":"Serotonin 2A receptor function: ligand-dependent mechanisms and pathways","author":"Raote","year":"2007"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1124\/mol.112.078626","article-title":"Functional selectivity in serotonin receptor 2A (5-HT2A) endocytosis, recycling, and phosphorylation","volume":"83","author":"Raote","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0163-7258(01)00169-3","article-title":"Multiplicity of mechanisms of serotonin receptor signal transduction","volume":"92","author":"Raymond","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0200","series-title":"serotonin receptors and their ligands","first-page":"199","article-title":"The 5-HT2-type receptor family","author":"Ronken","year":"1997"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0163-7258(98)00019-9","article-title":"5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C) where structure meets function","volume":"79","author":"Roth","year":"1998","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pbb.2008.07.004","article-title":"Effect of (\u2212)-trans-PAT, a novel 5-HT2Creceptor agonist, on intake of palatable food in mice","volume":"91","author":"Rowland","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0215","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1124\/mol.58.5.877","article-title":"Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5","volume":"58","author":"Shapiro","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0220","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1242\/jcs.179994","article-title":"Regulators of actin filament barbed ends at a glance","volume":"129","author":"Shekhar","year":"2016","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.thromres.2003.12.002","article-title":"Serotonin-2A receptor gene polymorphisms are associated with serotonin-induced platelet aggregation","volume":"112","author":"Shimizu","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0230","series-title":"Serotonin receptors and their ligands","first-page":"215","article-title":"5-HT2 receptor antagonists: (potential) therapeutics","author":"Soudijn","year":"1997"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0235","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/S1092852916000602","article-title":"Parkinson's disease psychosis as a serotonin-dopamine imbalance syndrome","volume":"21","author":"Stahl","year":"2016","journal-title":"CNS Spectr"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0240","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1074\/jbc.M805705200","article-title":"Ribosomal S6 kinase 2 directly phosphorylates the 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor, thereby modulating 5-HT2A signaling","volume":"284","author":"Strachan","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0245","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1124\/mol.109.061440","article-title":"Genetic deletion of p90 ribosomal S6 kinase 2 alters patterns of 5-hydroxytryptamine 2A serotonin receptor functional selectivity","volume":"77","author":"Strachan","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0250","author":"Tissue expression of HTR2A\u2014the human protein atlas"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0260","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1073\/pnas.89.10.4708","article-title":"Actions of dopamine and dopaminergic drugs on cloned serotonin receptors expressed in Xenopus oocytes","volume":"89","author":"Woodward","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0265","doi-asserted-by":"crossref","first-page":"21901","DOI":"10.1074\/jbc.M301905200","article-title":"A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction","volume":"278","author":"Xia","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0270","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.yjmcc.2008.12.019","article-title":"Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors","volume":"46","author":"Yabanoglu","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0275","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.108.143461","article-title":"Serotonin 5-hydroxytryptamine 2A receptor activation suppresses tumor necrosis factor-\u03b1-induced inflammation with extraordinary potency","volume":"327","author":"Yu","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2019.03.056_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2015.00225","article-title":"The role of serotonin 5-HT2A receptors in memory and cognition","volume":"6","author":"Zhang","year":"2015","journal-title":"Front Pharmacol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452219302180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452219302180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T15:58:01Z","timestamp":1759679881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452219302180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":56,"alternative-id":["S0306452219302180"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2019.03.056","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine requires unique residues to signal via the serotonin 2A receptor","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2019.03.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}